Supp. Figure S2 : Family M. Individuals 1, 2, 7 (obligate carrier), and 9 had been sequenced and were used in our analysis.
: Family L. Individuals labeled "21" and "22" had been sequenced and are the only two individuals used in our analysis.
Family genotype data
The data for families S (Ataei- Kachouei et al., 2015) and L (Bespalova et al., 2001 ) have previously been published but sequencing for family L was only recently done for educational purposes. Family M has not previously been published but is one of a number of families with the same pathogenic variant (Mosse et al., 2004) and has recently been sequenced for instructional purposes. Details on sequencing may be found in the references in this paragraph, and in reference (Frampton et al., 2013) for family M. Data were furnished to us in the form of vcf files and were converted to plink transposed format with the following parameters:
--const-fid --allow-extra-chr --chr 1-22 --biallelic-only --maf 0.00000001 --output-missing-phenotype 0 --vcf-min-qual 10 --recode 12 transpose
The data contained a small fraction of indels (the pathogenic variant in family S is an indel). All individuals for family S were contained in the same vcf file with 6,347,882 variants; the pathogenic variant reported here is the only disease variant in the BRCA2 gene in this family. Files for family M were available individually and resulted in approximately 430,000 variants for each of the four individuals. For family L, the two individuals #21 and #22 furnished 45,506 and 44,646 variants, respectively. Thus, these variants were not used and the two vcf files were re-read without the "minimum quality" qualifier, which resulted in 6, 395,904 and 5,996,970 variants, respectively . To analyze members of families M and L combined for each family, individual plink genotype files were merged so that only those variants were retained with a known genotype for each individual, which resulted in 115,307 and 1,843,269 variants for families M (three affecteds) and L (two affecteds), respectively. No other filtering was applied.
Pregnant women resident in Avon, UK with expected dates of delivery 1st April 1991 to 31st December 1992 were invited to take part in the study. The initial number of pregnancies enrolled is 14,541 (for these at least one questionnaire has been returned or a "Children in Focus" clinic had been attended by 19/07/99). Of these initial pregnancies, there was a total of 14,676 foetuses, resulting in 14,062 live births and 13,988 children who were alive at 1 year of age.
When the oldest children were approximately 7 years of age, an attempt was made to bolster the initial sample with eligible cases who had failed to join the study originally. As a result, when considering variables collected from the age of seven onwards (and potentially abstracted from obstetric notes) there are data available for more than the 14,541 pregnancies mentioned above.
The number of new pregnancies not in the initial sample (known as Phase I enrolment) that are currently represented on the built files and reflecting enrolment status at the age of 18 is 706 (452 and 254 recruited during Phases II and III respectively), resulting in an additional 713 children being enrolled. The total sample size for analyses using any data collected after the age of seven is therefore 15,247 pregnancies, resulting in 15,458 foetuses. Of this total sample of 15,458 foetuses, 14,775 were live births and 14,701 were alive at 1 year of age.
A 10% sample of the ALSPAC cohort, known as the Children in Focus (CiF) group, attended clinics at the University of Bristol at various time intervals between 4 to 61 months of age. The CiF group were chosen at random from the last 6 months of ALSPAC births (1432 families attended at least one clinic). Excluded were those mothers who had moved out of the area or were lost to follow-up, and those partaking in another study of infant development in Avon.
Population data
Supp. Figures S4 and S5 below refer to the 1,927 individuals in the ALSPAC data analyzed by our approach. We focused on pathogenic dominant variants on chromosome 2 (see main paper). Figures S4 and S5 show H values in the vicinity of the two pathogenic variants with the best (lowest ranked) H values.
Supp. Figure S4 . Curve of H values for the pathogenic variant rs3214759 in the CRYGB gene (cataracts). The figure clearly shows the typical peak close to the pathogenic variant in inherited dominant disease variants.
Supp. Figure S5 . Curve of H values for the common intron variant rs1978890 in the PLCL1 gene. The figure demonstrates absence of a peak close to the variant. 
Statistical significance

